S
QTTB icon

Sachetta’s Q32 Bio QTTB Stock Holding History

Sachetta’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$1 – 1308
2024
Q1 		$1 Buy
+1
New +$14 ﹤0.01% 1151
2023
Q4 		– Hold
0
– – – 1150

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Sachetta's QTTB Position: Q2 2024 in Review

Sachetta sold out of Q32 Bio (QTTB) in Q2 2024, closing a stake of 1 share — an estimated $1 sold.

Sachetta first reported a position in QTTB in Q1 2024 and held it in 1 quarter. The position peaked at $1 in Q1 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q2 2024.

  • Sachetta reported no remaining Q32 Bio position as of Q2 2024 after selling out during the quarter.
  • Sachetta sold 1 Q32 Bio share in Q2 2024, an estimated $1.
  • Sachetta first reported a position in Q32 Bio in Q1 2024 and held it in 1 quarter.
  • Sachetta's Q32 Bio position peaked at $1 in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2024.

Based on Sachetta's 13F filing for Q2 2024, filed 7 Aug 2024.